Aesthetic surgery journal
-
Aesthetic surgery journal · Mar 2013
Multicenter StudyJuvederm ultra for lip enhancement: an open-label, multicenter study.
Juvéderm Ultra injectable gel (Allergan, Inc, Irvine, California) is approved in the United States to treat moderate to severe wrinkles and folds, such as nasolabial folds. It is also used to enhance the appearance of the lips. ⋯ Juvéderm Ultra injectable gel is safe and effective for lip enhancement. Scales for assessing lip fullness provide an objective method to determine the effectiveness of treatment.
-
Aesthetic surgery journal · Aug 2012
Multicenter StudyNatrelle style 410 form-stable silicone breast implants: core study results at 6 years.
The Natrelle Style 410 shaped, form-stable silicone gel implant (Allergan, Inc; Irvine, California) has been the subject of a pivotal study that supports potential US Food and Drug Administration approval of the device. The 3-year results of this study were reported previously. ⋯ These fifth-generation, form-stable implants represent another option to achieve desired aesthetic outcomes with minimal complications.
-
Aesthetic surgery journal · Feb 2012
Randomized Controlled Trial Multicenter StudyA two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty.
Two-year safety outcomes in patients who received DepoFoam bupivacaine during two prior breast augmentation studies were evaluated. ⋯ 2.
-
Aesthetic surgery journal · Jan 2012
Randomized Controlled Trial Multicenter StudyThe efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study.
Breast augmentation can result in significant postsurgical pain. ⋯ DepoFoam bupivacaine trended toward benefit versus bupivacaine HCl on most efficacy measures. Due to early termination, the study was underpowered to achieve statistical significance.
-
Aesthetic surgery journal · Jan 2008
Randomized Controlled Trial Multicenter StudyJuvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness.
A high concentration of crosslinked hyaluronic acid (HA) in a smooth, malleable formulation is the hallmark of the new Juvéderm dermal fillers. ⋯ These next-generation HA dermal fillers can be reliably expected to provide long-term correction, with Juvéderm Ultra lasting more than 9 months and Juvéderm Ultra Plus lasting for a year or more.